| Identification | More | [Name]
BOC-D-3,4-Dichlorophe | [CAS]
114873-13-1 | [Synonyms]
BOC-3,4-DICHLORO-D-PHENYLALANINE
BOC-3,4-DICHLORO-D-PHE-OH
BOC-(3,4-DI-CL)-D-PHE-OH
BOC-D-3,4-DICHLOROPHE
BOC-D-3,4-DICHLOROPHENYLALANINE
BOC-D-PHE(3,4-CL2)-OH
BOC-D-PHE(3,4-DI-CL)-OH
BOC-D-PHE(M,P-CL2)-OH
N-ALPHA-T-BOC-3,4-DICHLORO-D-PHENYLALANINE
N-ALPHA-T-BUTOXYCARBONYL-D-(3,4-DICHLOROPHENYL)ALANINE
N-ALPHA-TERT-BUTYLOXYCARBONYL-D-3,4-DICHLOROPHENYLALANINE
(R)-2-TERT-BUTOXYCARBONYLAMINO-3-(3,4-DICHLORO-PHENYL)-PROPIONIC ACID
RARECHEM BK PT 0119
(R)-N-BOC-3,4-DICHLOROPHENYLALANINE
tert-butoxycarbonyl-d-3,4-dichlorophenylalanine
(R)-N-boc-3,4-Dichlorophenylalanine(e.e.)
N-TERT-BUTOXYCARBONYL-D-3,4-DICHLORO PHENYLALANINE
3,4-Dichloro-D-phenylalanine, N-BOC protected
(R)-2-(tert-butoxycarbonylamino)-3-(3,4-dichlorophenyl)propanoic acid
N-ALPHA-T-BUTYLOXYCARBONYL-D-3,4-DICHLOROPHENYLALANINE | [Molecular Formula]
C14H17Cl2NO4 | [MDL Number]
MFCD00151887 | [Molecular Weight]
334.2 | [MOL File]
114873-13-1.mol |
| Chemical Properties | Back Directory | [Appearance]
white to off-white powder | [Melting point ]
120°C | [alpha ]
-15 º (c=1,MeOH) | [Boiling point ]
478.1±45.0 °C(Predicted) | [density ]
1.3859 (rough estimate) | [refractive index ]
1.6200 (estimate) | [storage temp. ]
-15°C | [form ]
Solid | [pka]
3.75±0.10(Predicted) | [color ]
White to off-white | [BRN ]
8428163 | [CAS DataBase Reference]
114873-13-1(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Safety Statements ]
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29242990 |
| Hazard Information | Back Directory | [Chemical Properties]
white to off-white powder | [Uses]
N-Boc-D-3,4-dichlorophenylalanine is used to prepare fluorinated β-aminoacyl 1,2,4-triazolo[4,3-a]piperazine amides as dipeptidyl peptidase IV inhibitors and antidiabetic agents. It is also used in the synthesis of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide as a potent and orally active dual neurokinin NK1/NK2 receptor antagonist. | [reaction suitability]
reaction type: Boc solid-phase peptide synthesis |
|
|